Comparison of the efficacy of taxanes with carboplatin and anthracyclines with taxanes in neoadjuvant chemotherapy for stage II-III triple negative breast cancer: a retrospective analysis.

J Cancer Res Clin Oncol · 2024 · PMC11153300 · PMID 38836955

Europe PMC DOI

hedged sentences

0.0510

closest p · 1.0× alpha

0.0540

boldest claim

The sentences

borderline significantP = 0.051so close (0.05 < p ≤ 0.1)

The treatment group is borderline significant ( P = 0.051).

also in 2,000 other papers

approaches statistical significanceP = 0.054so close (0.05 < p ≤ 0.1)

The treatment regimen approaches statistical significance (HR = 2.854; 95% CI 0.980–8.311; P = 0.054).

also in 34 other papers

close-to-significantno p-value reported

Clinical TNM stage and RCB grade were identified as independent factors influencing EFS and OS, while treatment group was identified as an independent factor influencing EFS, with a close-to-significant impact on OS.

also in 53 other papers

did not reach statistical significanceno p-value reported

However, the improvement in OS did not reach statistical significance (Loibl et al. 2018a ).

also in 24,045 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.